Quetiapine XR in Schizophrenic Patients

PHASE3TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Schizophrenia
Interventions
DRUG

Quetiapine XR

Quetiapine XR (Seroquel Prolong®) extended-release tablets à 50 mg und 200 mg. Seroquel Prolong® should be administered as the only neuroleptics preferably once daily, preferably in the evening. The recommended initial dose is 200 mg/day. Patients should be titrated within a dose range of 400 - 800 mg/day depending on the response and tolerance of the individual patient. Dose increases can be made at intervals as short as 1 day and in increments of up to 200 mg/day. Seroquel Prolong® tablets should be swallowed whole and not split, chewed or crushed.

Trial Locations (3)

30625

Hannover Medical School, Hanover

31319

Klinikum Wahrendorff, Sehnde

32312

Krankenhaus Lübbecke, Lübbecke

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Hannover Medical School

OTHER